Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010

Share Article

Cobalis Corp. is holding the second Investor Update Conference Call to provide investors and shareholders with further details and the latest updates about a range of important securities, financial and legal issues on October 5, 2010.

News Image
Corbalis Corp. to provide further details about securities, financial and legal issues in Investor Conference Call on October 5.

Cobalis Corp. (Pink Sheets: CLSC.PK) is holding the second Investor Update Conference Call to provide investors and shareholders with further details and the latest updates about a range of important securities, financial and legal issues.

Shareholders and investors MUST RSVP to participate in this conference call, to be held Tuesday, October 5, 2010 at 1:15pm Pacific Time. Interested parties may RSVP to participate in the call by contacting Cobalis at (949) 260-0123 between 9:00 am and 5:00 pm Pacific Time, Monday through Friday, to get the conference call dial-in number and passcode.

The agenda of this call will include: Financial status and private funding; details of current legal and corporate issues; update on the recent SEC complaint and resolution; resumption of trading; launch update; current legal settlements and how the Company is meeting the terms of its agreements; overview of additional revenue opportunities; what happened with previously planned product release dates.

There will also be a Question and Answer opportunity as well as opportunities following the Conference Call for one-on-one discussions with interested parties.

FORWARD LOOKING STATEMENTS
Cobalis Corp., expectation of results and other forward-looking statements contained in this email involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those expected are the following: business conditions and general economic conditions; competitive factors, such as pricing and marketing efforts; and the pace and success of product research and development. These and other factors may cause expectations to differ.

ABOUT COBALIS CORP—PREHISTIN®
Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, The World’s FIRST Pre-Histamine, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is available without prescription for both long-term and daily use.

For PreHistin® product information and ordering please visit at http://www.PreHistin.com or call toll free 1-877-4POLLEN. For additional company information please visit the corporate website at http://www.Cobalis.com

CONTACT
Cobalis Corp.
16795 Von Karman, Suite 200
Irvine, CA 92606
949-260-0123
Chas Radovich, President
info(at)cobalis(dot)com

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chas Radovich
Visit website